配分額 *注記 |
4,680千円 (直接経費: 3,600千円、間接経費: 1,080千円)
2027年度: 1,300千円 (直接経費: 1,000千円、間接経費: 300千円)
2026年度: 1,040千円 (直接経費: 800千円、間接経費: 240千円)
2025年度: 2,340千円 (直接経費: 1,800千円、間接経費: 540千円)
|
研究開始時の研究の概要 |
I will clarify the main cell death pathways and I will highlight the role of fundamental factors which may end ups in cancer cell resistance to HHP therapy. This study will include 4 phases: identification of the death molecular mechanisms using (1) cell suspensions, (2) cell sheets, and (3) spheroids and cultured dermis and, then (4) the comparative analysis of 3 models results of HHP and LN treatments.
|